je.st
news
Tag: teva
Developer plans mixed-use project in Doral after buying former Teva plant
2015-01-14 17:47:31| Biotech - Topix.net
An affiliate of Hines plans to build a retail, hotel and commercial project in Doral after purchasing the former Teva Pharmaceuticals plant. Two affiliates of the Israel-based company sold a 78,130-square-foot building on 11.9 acres of land to 8800 Doral LLC, an affiliate of Houston-based Hines, for $26 million.
Tags: project
plans
buying
plant
Teva: New Generic Launches Will Benefit Earnings
2015-01-07 20:18:26| Biotech - Topix.net
Recently, Teva has been authorized by the US Food Drug and Administration to introduce the generic counterpart of Diovan "Valsartan" tablets in the US market. The anticipated elevation in earnings is calculated to be $29 million.
Tags: benefit
generic
earnings
launches
Teva to return rights to experimental cancer therapy
2014-12-30 17:21:14| Biotech - Topix.net
Teva Pharmaceutical Industries Ltd. is returning to OncoGenex the rights to a cancer drug, on which the companies had previously collaborated. Under the terms of an initial agreement, Teva will make a $27 million to OncoGenex of Bothell, Wash.
Tags: rights
return
cancer
experimental
Maxim Group Increases Teva Pharmaceutical Industries Ltd Price Target to $70.00
2014-11-10 16:52:18| Biotech - Topix.net
The firm currently has a "buy" rating on the stock. Maxim Group's price objective points to a potential upside of 21.32% from the company's current price.
Tags: price
group
target
industries
FTC sues AbbVie, Teva over testosterone replacement therapy deal
2014-09-09 11:55:23| Biotech - Topix.net
The Federal Trade Commission filed a complaint Monday against AbbVie and Teva Pharmaceutical Industries alleging the companies illegally blocked American consumers' access to lower-cost versions of the testosterone replacement therapy AndroGel. According to the FTC complaint, AbbVie of Chicago and its partner Besins Healthcare Inc. allegedly filed baseless patent infringement lawsuits against potential generic competitors to delay the introduction of lower-priced versions of AndroGel, which generates more than $1 billion a year in annual sales.
Tags: deal
therapy
replacement
sues
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] next »